{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VCYT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:49:08.899Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":686,"canonical_name":"VERACYTE, INC.","cik":"0001384101","uei":null,"lei":null,"duns":null,"ticker":"VCYT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":73},"count":73,"timeline":[{"ts":"2026-09-24","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-24","url_slug":"/sec/cik-0001384101/144/0001950047-26-009791","accession_number":"0001950047-26-009791","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-22","url_slug":"/sec/cik-0001384101/4/0001991536-26-000013","accession_number":"0001991536-26-000013","importance":30},{"ts":"2026-09-21","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-21","url_slug":"/sec/cik-0001384101/144/0001950047-26-009711","accession_number":"0001950047-26-009711","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-16","url_slug":"/sec/cik-0001384101/4/0001819880-26-000004","accession_number":"0001819880-26-000004","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"8-K","title":"8-K — VERACYTE, INC. — 2026-09-14","url_slug":"/sec/cik-0001384101/8-k/0001384101-26-000049","accession_number":"0001384101-26-000049","importance":35},{"ts":"2026-09-14","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-14","url_slug":"/sec/cik-0001384101/144/0001950047-26-009444","accession_number":"0001950047-26-009444","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-009139","accession_number":"0001950047-26-009139","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-009145","accession_number":"0001950047-26-009145","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-009146","accession_number":"0001950047-26-009146","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/4/0001539796-26-000019","accession_number":"0001539796-26-000019","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/4/0001584145-26-000009","accession_number":"0001584145-26-000009","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/4/0001649245-26-000009","accession_number":"0001649245-26-000009","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/4/0001823563-26-000016","accession_number":"0001823563-26-000016","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/4/0001914620-26-000013","accession_number":"0001914620-26-000013","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-04","url_slug":"/sec/cik-0001384101/4/0001991536-26-000011","accession_number":"0001991536-26-000011","importance":30},{"ts":"2026-09-04","kind":"sec.insider.2477","reporter":"Chambers Rebecca","title":"Chief Financial Officer","shares":2477,"price_per_share":42.8059,"usd_value":106030,"security_title":"Common Stock","importance":15.1060302143},{"ts":"2026-09-04","kind":"sec.insider.2154","reporter":"McGuire Annie","title":"EVP, General Counsel","shares":2154,"price_per_share":42.7916,"usd_value":92173,"security_title":"Common Stock","importance":15.0921731064},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-09-03","url_slug":"/sec/cik-0001384101/4/0001846905-26-000006","accession_number":"0001846905-26-000006","importance":30},{"ts":"2026-09-02","kind":"sec.insider.3639","reporter":"Febbo Phillip G.","title":"Chief Scientific & Med Officer","shares":3639,"price_per_share":44.88,"usd_value":163318,"security_title":"Common Stock","importance":15.16331832},{"ts":"2026-09-02","kind":"sec.insider.3603","reporter":"Chambers Rebecca","title":"Chief Financial Officer","shares":3603,"price_per_share":44.88,"usd_value":161703,"security_title":"Common Stock","importance":15.16170264},{"ts":"2026-09-02","kind":"sec.insider.3215","reporter":"McGuire Annie","title":"EVP, General Counsel","shares":3215,"price_per_share":44.88,"usd_value":144289,"security_title":"Common Stock","importance":15.1442892},{"ts":"2026-09-02","kind":"sec.insider.1361","reporter":"Wygant Jonathan","title":"VP, Chief Accounting Officer","shares":1361,"price_per_share":44.88,"usd_value":61082,"security_title":"Common Stock","importance":15.06108168},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-09-01","url_slug":"/sec/cik-0001384101/144/0001950047-26-008941","accession_number":"0001950047-26-008941","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"10-Q","title":"10-Q — VERACYTE, INC. — 2026-07-31","url_slug":"/sec/cik-0001384101/10-q/0001384101-26-000044","accession_number":"0001384101-26-000044","importance":45},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — VERACYTE, INC. — 2026-07-30","url_slug":"/sec/cik-0001384101/8-k/0001384101-26-000042","accession_number":"0001384101-26-000042","importance":35},{"ts":"2026-06-18","kind":"sec.form144","reporter":"KARIN EASTHAM","title":"Director","shares":3729,"usd_value":191260,"security_title":"Common","approx_sale_date":"2026-06-18","accession_number":"0001950047-26-006311","importance":40.038252082},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"EASTHAM KARIN","title":null,"shares":3200,"price_per_share":52.7832,"usd_value":168906,"security_title":"Common Stock","importance":35.16890624},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"EASTHAM KARIN","title":null,"shares":529,"price_per_share":53.5504,"usd_value":28328,"security_title":"Common Stock","importance":35.0283281616},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-15","url_slug":"/sec/cik-0001384101/4/0001728374-26-000004","accession_number":"0001728374-26-000004","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-15","url_slug":"/sec/cik-0001384101/4/0001819880-26-000002","accession_number":"0001819880-26-000002","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-15","url_slug":"/sec/cik-0001384101/4/0001846905-26-000002","accession_number":"0001846905-26-000002","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-15","url_slug":"/sec/cik-0001384101/4/0001940521-26-000002","accession_number":"0001940521-26-000002","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-15","url_slug":"/sec/cik-0001384101/4/0002034921-26-000002","accession_number":"0002034921-26-000002","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — VERACYTE, INC. — 2026-06-11","url_slug":"/sec/cik-0001384101/8-k/0001384101-26-000038","accession_number":"0001384101-26-000038","importance":35},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"JONES EVAN/ FA","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"EASTHAM KARIN","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"EPSTEIN ROBERT S","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Shafer David Brent","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Bhanji Muna","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Holstein Jens","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Miller Thomas F.","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Barr Eliav","title":null,"shares":5272,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8","title":"S-8 — VERACYTE, INC. — 2026-06-10","url_slug":"/sec/cik-0001384101/s-8/0001384101-26-000036","accession_number":"0001384101-26-000036","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — VERACYTE, INC. — 2026-06-05","url_slug":"/sec/cik-0001384101/schedule-13g-a/0000315066-26-001411","accession_number":"0000315066-26-001411","importance":30},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Stapley Marc","title":"Chief Executive Officer","shares":138051,"price_per_share":50.1234,"usd_value":6919585,"security_title":"Common Stock","importance":41.9195854934},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Leite John","title":"Global Chief Commercial Off","shares":13975,"price_per_share":50.0703,"usd_value":699732,"security_title":"Common Stock","importance":35.6997324425},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Chambers Rebecca","title":"Chief Financial Officer","shares":1961,"price_per_share":50.0913,"usd_value":98229,"security_title":"Common Stock","importance":35.0982290393},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"McGuire Annie","title":"EVP, General Counsel","shares":1776,"price_per_share":50.1168,"usd_value":89007,"security_title":"Common Stock","importance":35.0890074368},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Chambers Rebecca","title":"Chief Financial Officer","shares":1600,"price_per_share":49.2836,"usd_value":78854,"security_title":"Common Stock","importance":35.07885376},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"McGuire Annie","title":"EVP, General Counsel","shares":1400,"price_per_share":49.3061,"usd_value":69029,"security_title":"Common Stock","importance":35.06902854},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-005651","accession_number":"0001950047-26-005651","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-005655","accession_number":"0001950047-26-005655","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-005656","accession_number":"0001950047-26-005656","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/144/0001950047-26-005662","accession_number":"0001950047-26-005662","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/4/0001539796-26-000015","accession_number":"0001539796-26-000015","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/4/0001584145-26-000007","accession_number":"0001584145-26-000007","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/4/0001649245-26-000007","accession_number":"0001649245-26-000007","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/4/0001823563-26-000014","accession_number":"0001823563-26-000014","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/4/0001914620-26-000011","accession_number":"0001914620-26-000011","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-06-04","url_slug":"/sec/cik-0001384101/4/0001991536-26-000009","accession_number":"0001991536-26-000009","importance":30},{"ts":"2026-06-04","kind":"sec.insider.m","reporter":"Stapley Marc","title":"Chief Executive Officer","shares":138051,"price_per_share":36.6,"usd_value":5052667,"security_title":"Common Stock","importance":20.052666600000002},{"ts":"2026-06-02","kind":"sec.insider.f","reporter":"Stapley Marc","title":"Chief Executive Officer","shares":9012,"price_per_share":47.8,"usd_value":430774,"security_title":"Common Stock","importance":15.4307736},{"ts":"2026-06-02","kind":"sec.insider.f","reporter":"Leite John","title":"Global Chief Commercial Off","shares":4059,"price_per_share":47.8,"usd_value":194020,"security_title":"Common Stock","importance":15.1940202},{"ts":"2026-06-02","kind":"sec.insider.f","reporter":"Febbo Phillip G.","title":"Chief Scientific & Med Officer","shares":3730,"price_per_share":47.8,"usd_value":178294,"security_title":"Common Stock","importance":15.178294},{"ts":"2026-06-02","kind":"sec.insider.f","reporter":"Chambers Rebecca","title":"Chief Financial Officer","shares":3693,"price_per_share":47.8,"usd_value":176525,"security_title":"Common Stock","importance":15.1765254},{"ts":"2026-06-02","kind":"sec.insider.f","reporter":"McGuire Annie","title":"EVP, General Counsel","shares":3292,"price_per_share":47.8,"usd_value":157358,"security_title":"Common Stock","importance":15.1573576},{"ts":"2026-06-02","kind":"sec.insider.f","reporter":"Wygant Jonathan","title":"VP, Chief Accounting Officer","shares":1361,"price_per_share":47.8,"usd_value":65056,"security_title":"Common Stock","importance":15.0650558},{"ts":"2026-05-20","kind":"sec.form144","reporter":"ROBERT EPSTEIN","title":"Director","shares":10000,"usd_value":416900,"security_title":"Common","approx_sale_date":"2026-05-20","accession_number":"0001950047-26-004846","importance":40.08338},{"ts":"2026-05-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — VERACYTE, INC. — 2026-05-13","url_slug":"/sec/cik-0001384101/schedule-13g-a/0001193125-26-220565","accession_number":"0001193125-26-220565","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — VERACYTE, INC. — 2026-05-12","url_slug":"/sec/cik-0001384101/schedule-13g/0000093751-26-000310","accession_number":"0000093751-26-000310","importance":55},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — VERACYTE, INC. — 2026-05-08","url_slug":"/sec/cik-0001384101/4/0001914620-26-000010","accession_number":"0001914620-26-000010","importance":30},{"ts":"2026-05-06","kind":"sec.insider.s","reporter":"McGuire Annie","title":"SVP, General Counsel","shares":5102,"price_per_share":40,"usd_value":204080,"security_title":"Common Stock","importance":35.20408},{"ts":"2026-05-06","kind":"sec.insider.s","reporter":"McGuire Annie","title":"SVP, General Counsel","shares":5102,"price_per_share":38.05,"usd_value":194131,"security_title":"Common Stock","importance":35.1941311}]}